AccuMetab™ Human UGT Control Sf9 Microsome Fraction

CAT#: ITS-0426-YL104
Product Type: Control Fraction
Brand: AccuMetab
Development Stage: ADME
ADME Research Domain: Metabolism
Short Description
Zero-background microsome control for accurate ADME assay baseline validation.
Brand
AccuMetab
Development Stage
ADME
ADME Research Domain
Metabolism
Background
This blank insect cell microsome fraction serves as the definitive negative control for all UDP-glucuronosyltransferase screening assays. Its inclusion is scientifically required to isolate the specific activity of recombinant UGTs from any inherent background substrate depletion or non-specific chemical degradation.
Key Features
Native Sf9 microsomes lacking recombinant UDP-glucuronosyltransferases; Absolute zero-background baseline for Phase II UGT validation; Isolates true enzyme-mediated clearance from substrate depletion; Essential for validating high-fidelity ADME glucuronidation data
Applications
Background Subtraction, Assay Control
Research Areas
ADME; Assay Control
Expression System
Sf9 host insect cell microsome preparations.
Physical Form
Liquid
Size
0.5 nmol; 1 nmol; 4 nmol; 10 mg
Storage
-80°C
Storage Comment
When stored at -80°C, our product remains stable and retains full functional activity for up to 10 years.
Note
For bulk pricing or custom reagent inquiries, please contact us by email or phone. Products are shipped on ice via FedEx.
Restrictions
For Research Use Only (RUO). Not intended for diagnostic or therapeutic use.
Shipping
Our enzyme products are shipped at -80°C.
For Research Use Only | Not For Clinical Use
Online Inquiry